Far-infrared Therapy for Hemodialysis Patients
January 6, 2024
Abstract
Although the arteriovenous fistula is considered the best access due to low complications, it faces challenges such as poor maturation rates and patency issues. The present paper describes the current status of far-infrared therapy as a treatment modality to enhance AVF maturation and access survival. The mechanism underlying FIR therapy involves vasodilatory, angiogenesis, and the induction of vasodilation and anti-inflammatory factors. Thermal effect of FIR therapy involve upregulation of endothelial nitric oxide synthase, while non-thermal effects include reduced oxidative stress and improved endothelial function. In conclusion, FIR therapy presents potential benefits for improving vascular access flow and survival.
Want to know more?
Contact us for more detail
On 9–10 February 2026, FIRAPY joined Unex Corporation (Japan) at World Health Expo – WHX Dubai 2026, held at the Dubai Exhibition Centre, Expo City Dubai. This was FIRAPY’s first time participating in WHX Dubai, marking an important step in expanding our presence in the Middle East and surrounding regions. WHX Dubai (World Health Expo) is one of the region’s most important healthcare exhibitions, bringing together thousands of healthcare professionals, industry leaders, and innovators from more than 100 countries. The event combines a large-scale trade show with conferences and forums that highlight new technologies, clinical best practices, and emerging models of care.
Authors: Hamed Ali Ahmad Alshahri, Omaima Farah Al Jabal Published in: World Advances in Renal Medicine Vol.1, No.3 (2025) Read the full article
FIRAPY made its debut at the Chilean Society of Nephrology Congress, presented by Mirusta and featured in a fistula care workshop, sparking local clinical interest.
